BRCA2 and Fanconi anemia: Germline mutations of Brca2 are associated with cancer prone syndromes and Fanconi anemia, and absence of a functional BRCA2 protein induces increased cell sensitivity to DNA crosslinking agents (10); thus, hAGT activity and degradation might also affect other DNA repair pathways.